There are some data suggesting that the natural history of 
Introduction

Statistical methods
Chronic lymphocytic leukemia (CLL) is the most frequent form of leukemia in Western countries. The knowledge of its natural history (sex and age distribution, clinical stage at presenBoth parametric (t-test, comparison of two proportions) and tation, survival, impact on life expectancy) is important for the nonparametric ( 2 test) were used. 7 Survival curves were calclinical management of the patients. culated according to the Kaplan-Meier method 8 and comAmong the leukemias, CLL has the most variable course and pared by means of the log-rank test. 9 For the calculations of the widest range of life span. 1 The survival of some patients the expected survival, we used the Spanish life tables corremay be as short as a few months, while other patients may sponding to the years 1960, 1970, 1975, 1980, 1985 (Figure 1 ), it is evident that all the popu-1980-1989, respectively. The most important characteristics lation of group II has been displaced to higher ages when of the natural history of CLL such as sex, and age distribution, compared to group I. As a result, the proportion of patients stage at presentation, survival probability, and impact of the у70 years in group II was significantly higher than in group disease on expected survival, have been analyzed and com-I (43.3 vs 20.3%; P Ͻ 0.0001). pared by appropriate statistical methods. Comparison of both groups concerning the age distribution.
Stage at diagnosis
Survival analyses
The survival probability and its comparison with the sex-and age-matched population survival is depicted in Figure 2 (a and b). The median survival was significantly higher in group II (median 11.1) than in group I (median 5.3 years), (P Ͻ 0.0001). This was associated with a much lower impact of the disease on life expectancy in group II. Figure 2 shows how the difference between actual survival probability and the sex-and age-matched general population is much smaller in the most recent cohort (group II). This is reflected also in lower statistical significance (P = 0.047 in the second cohort vs 0.000007 in the first cohort). Finally, the mean difference between observed and expected survival probability was also markedly reduced from 0.26 (95% CI, 0.234-0.285) in group I to 0.08 (95% CI, 0.065-0.095) in group II (P = 0.00000005).
The survival analysis by stages shows that only patients in the high-risk group (stage C) lived significantly longer in group Discussion the age at diagnosis of the second cohort should be lower. However, the reverse was true: all the population of the When comparing the more recent CLL cohort with the older one, the two most striking differences are: (1) longer survival, second cohort moved to higher ages and the proportion of patients у70 years was significantly higher. and (2) the higher proportion of patients presenting in early clinical stage. Since our data are not derived from a tumor Another possible explanation is that due to improved diagnostic methods and health care for the elderly population, a registry of a general population, such a difference might be attributed to an accrual bias. This is unlikely, since the mechhigher number of patients in low-risk clinical stage would be now identified, whereas in older times, some of them would anisms of patients' referral to our institution have not changed. Moreover, the above mentioned differences have been be missed and eventually dying from causes unrelated to CLL. Although the diagnosis of CLL is not difficult, underdiagnosis observed by several authors from different geographic areas. 3, 4, 11, 12 world-wide is considerable 13 and may have been higher in previous times. The higher age and increasing proportion of When analyzing the cause of longer survival, it is evident that this is mostly due to the fact that a greater proportion of patients in stage A in the more recent cohort is consistent with this explanation. Additionally, it is likely that earlier under the patients present in low-risk clinical stage. Although improvements in the management of the disease might also play a diagnosis of CLL some other conditions were included which due to better diagnostic procedures are currently separated. role, the influence of this is most likely marginal and would be only reflected in patients with advanced (Binet's C) disease.
For example, the inclusion of cases of mantle-zone lymphoma in leukemic phase, a CD5 + B cell malignancy with worse The major question is whether the above-mentioned changes constitute a true change in the natural history of the prognosis than classical CLL, 5,14 might contribute to a shorter general survival. However, the relative rarity of such disorders disease or a simple artifact. At first glance, it could be thought that an earlier diagnosis of the disease could explain the when compared to CLL, renders this interpretation improbable. increased proportion of cases in early-or low-risk clinical stage. If this was the only factor responsible for the change, There is an additional explanation which probably consti- between 50 and 70 years. 16 On the other hand, the increasing
